Abstract:Objective To study the neuroprotective agents utilization in 6 cities (Beijing, Tianjin, Shanghai, Guangzhou, Hangzhou, Chengdu) of China from 2010 to 2015, in order to provide basis for promoting the rational use of drugs and medical resources. Methods "Hospital prescription analysis cooperation project" was used for data collection. The average daily cost value (DDDc), drug utilization index (DUI), serial number ratio (B/A value) and medication combination were calculated. Results The drugs that ranked in the front of DDDc were basically similar kinds in different regions. Those drugs were all general types, including Brain Nucleoside Carnosine, Edaravone, Ganglioside, Fasudil and Mouse Nerve Growth Factor. These drugs were frequently used with high cost and heavy economic burden. There were 3 kinds of drugs with the DUI > 1.0, which were Gangliosides, Mouse Nerve Growth Factor and Deproteinized Calf blood Serum. These drugs were excessive use in clinic and they were not rational used. The neuroprotective agents were most given by the single way, the double combination therapy had increased from 5.29% in 2010 to 14.89% in 2015. Conclusion There are excessive use of neuroprotective agents in these regions. The rational use of neuroprotective agents is deserved more attention.
王慧媛 杨莉 赵志刚▲. 我国6城市2010~2015年神经保护剂用药情况分析[J]. 中国医药导报, 2017, 14(23): 137-143.
WANG Huiyuan YANG Li ZHAO Zhigang▲. Analysis of the medication situation of neuroprotective agents from 2010 to 2015 in 6 cities of our country. 中国医药导报, 2017, 14(23): 137-143.